Oklahoma City will be site of the nonprofit alliance’s first major program roll out.
Desperate times call for desperate measures.
In MS, immune cells attack the protective covering of nerves in the brain, causing vision problems, tremors, paralysis, painful spasms, imbalance and cognitive changes.
OMRF scientists need volunteers for the world’s first lupus prevention study.
David Key had never heard of sarcoidosis—until the rare disease stole his health.
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.